share_log

Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3

Benchmark Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $3

Benchmark 以买入评级开始对 Nutex Health 进行报道,宣布目标价为 3 美元
Benzinga Real-time News ·  2022/12/23 08:34

Benchmark analyst Bill Sutherland initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $3.

基准分析师Bill Sutherland以买入评级启动Nutex Health(纳斯达克:NUTX)的报道,并宣布目标价为3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发